Payment overview · 2025
General Payments
$921.90
39 reported records · 17 companies
Healthcare provider profile · identity verified
Bohdan A Lebedowicz, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ROLLA, MO · NPI 1023087731
Verified facts
What the public records show
CMS Open Payments records show Bohdan A Lebedowicz, MD received $921.90 in general payments during 2025 across 39 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 19.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 25 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Ingrezza, Ozempic, Rexulti, Shingrix.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 70 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Lumigan by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 94 claims for Trelegy Ellipta by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Ingrezza by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Ozempic by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 100 claims for Rexulti by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1771 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $181.19 | 19.6% | 11 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $164.73 | 17.9% | 6 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $140.58 | 15.2% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $92.27 | 10.0% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $45.27 | 4.9% | 3 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $42.76 | 4.6% | 2 | 2025 |
| Sage Therapeutics, LLC | Unresolved — no canonical attribution shown | $39.61 | 4.3% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $37.10 | 4.0% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $29.56 | 3.2% | 2 | 2025 |
| Radius Health, Inc. | Unresolved — no canonical attribution shown | $21.65 | 2.4% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $20.84 | 2.3% | 1 | 2025 |
| Pharmacosmos Therapeutics Inc. | Unresolved — no canonical attribution shown | $20.65 | 2.2% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $20.02 | 2.2% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $18.97 | 2.1% | 1 | 2025 |
| Viatris Specialty LLC | Unresolved — no canonical attribution shown | $16.47 | 1.8% | 1 | 2025 |
| Supernus Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $15.13 | 1.6% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.10 | 1.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $921.90 | 39 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $181.19 | 11 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $140.58 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $130.92 | 4 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $92.27 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $45.27 | 3 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $45.27 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $42.76 | 2 | 2025 |
Source payment records
|
|||||
| ZURZUVAE Normalized: zurzuvae |
Drug | Sage Therapeutics, LLC | $39.61 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $33.81 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $24.87 | 2 | 2025 |
Source payment records
|
|||||
| Tymlos Normalized: tymlos |
Drug | Radius Health, Inc. | $21.65 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $20.84 | 1 | 2025 |
Source payment records
|
|||||
| MONOFERRIC Normalized: monoferric |
Drug | Pharmacosmos Therapeutics Inc. | $20.65 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.02 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $19.45 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $19.45 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $18.97 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $17.65 | 1 | 2025 |
Source payment records
|
|||||
| YUPELRI Normalized: yupelri |
Drug | Viatris Specialty LLC | $16.47 | 1 | 2025 |
Source payment records
|
|||||
| Qelbree Normalized: qelbree |
Drug | Supernus Pharmaceuticals, Inc. | $15.13 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $15.10 | 1 | 2025 |
Source payment records
|
|||||
| BEXSERO Normalized: bexsero |
Biological | GlaxoSmithKline, LLC. | $15.10 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.10 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.85 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $14.71 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AREXVY arexvy |
2025 | Arexvy | 2024 | 26 | exact normalized | Medicare Part D |
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 93 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 46 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 100 | exact normalized | Medicare Part D |
| SHINGRIX shingrix |
2025 | Shingrix | 2024 | 28 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
70 | 12 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
26 | 26 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
28 | 20 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
94 | 20 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
93 | 11 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
46 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
100 | 13 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1771 | 165 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 2224 | 274 |
| Eliquis | Apixaban | 1771 | 165 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1717 | 255 |
| Potassium Chloride | Potassium Chloride | 1645 | 255 |
| Gabapentin | Gabapentin | 1542 | 232 |
| Furosemide | Furosemide | 1512 | 249 |
| Amlodipine Besylate | Amlodipine Besylate | 1257 | 198 |
| Lisinopril | Lisinopril | 1168 | 191 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1008 | 177 |
| Metoprolol Succinate | Metoprolol Succinate | 881 | 132 |
| Escitalopram Oxalate | Escitalopram Oxalate | 865 | 116 |
| Jardiance | Empagliflozin | 854 | 67 |
| Donepezil Hcl | Donepezil Hcl | 852 | 109 |
| Pantoprazole Sodium | Pantoprazole Sodium | 805 | 159 |
| Metformin Hcl | Metformin Hcl | 793 | 115 |
| Myrbetriq | Mirabegron | 764 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 753 | 120 |
| Trazodone Hcl | Trazodone Hcl | 703 | 117 |
| Sertraline Hcl | Sertraline Hcl | 694 | 97 |
| Memantine Hcl | Memantine Hcl | 679 | 79 |
| Tamsulosin Hcl | Tamsulosin Hcl | 659 | 101 |
| Quetiapine Fumarate | Quetiapine Fumarate | 636 | 99 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 621 | 86 |
| Divalproex Sodium | Divalproex Sodium | 603 | 78 |
| Carvedilol | Carvedilol | 585 | 97 |
| Metoprolol Tartrate | Metoprolol Tartrate | 560 | 99 |
| Tramadol Hcl | Tramadol Hcl | 542 | 93 |
| Lorazepam | Lorazepam | 537 | 117 |
| Duloxetine Hcl | Duloxetine Hcl | 536 | 75 |
| Levetiracetam | Levetiracetam | 491 | 65 |
| Famotidine | Famotidine | 475 | 77 |
| Olanzapine | Olanzapine | 473 | 81 |
| Losartan Potassium | Losartan Potassium | 463 | 84 |
| Buspirone Hcl | Buspirone Hcl | 459 | 79 |
| Mirtazapine | Mirtazapine | 452 | 78 |
| Omeprazole | Omeprazole | 436 | 90 |
| Oxycodone Hcl | Oxycodone Hcl | 429 | 67 |
| Januvia | Sitagliptin Phosphate | 418 | 29 |
| Simvastatin | Simvastatin | 391 | 54 |
| Xarelto | Rivaroxaban | 384 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 348 | 88 |
| Spironolactone | Spironolactone | 348 | 70 |
| Fluticasone Propionate | Fluticasone Propionate | 337 | 107 |
| Risperidone | Risperidone | 331 | 42 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 325 | 45 |
| Hydralazine Hcl | Hydralazine Hcl | 324 | 54 |
| Montelukast Sodium | Montelukast Sodium | 308 | 51 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 292 | 48 |
| Allopurinol | Allopurinol | 288 | 53 |
| Baclofen | Baclofen | 284 | 47 |
| Fluoxetine Hcl | Fluoxetine Hcl | 282 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 259 | 42 |
| Citalopram Hbr | Citalopram Hydrobromide | 258 | 42 |
| Ropinirole Hcl | Ropinirole Hcl | 255 | 47 |
| Topiramate | Topiramate | 244 | 31 |
| Fentanyl | Fentanyl | 243 | 49 |
| Finasteride | Finasteride | 243 | 49 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 242 | 35 |
| Clonazepam | Clonazepam | 235 | 33 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 233 | 34 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 232 | 82 |
| Warfarin Sodium | Warfarin Sodium | 228 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 215 | 30 |
| Aripiprazole | Aripiprazole | 208 | 29 |
| Amiodarone Hcl | Amiodarone Hcl | 194 | 39 |
| Alprazolam | Alprazolam | 192 | 44 |
| Megestrol Acetate | Megestrol Acetate | 192 | 51 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 189 | 38 |
| Sucralfate | Sucralfate | 188 | 34 |
| Prednisone | Prednisone | 187 | 43 |
| Benztropine Mesylate | Benztropine Mesylate | 186 | 23 |
| Ondansetron Odt | Ondansetron | 186 | 87 |
| Paroxetine Hcl | Paroxetine Hcl | 185 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 184 | 79 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 179 | 106 |
| Primidone | Primidone | 178 | 27 |
| Trulicity | Dulaglutide | 177 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 176 | 80 |
| Alendronate Sodium | Alendronate Sodium | 171 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 157 | 28 |
| Divalproex Sodium Er | Divalproex Sodium | 151 | 25 |
| Lamotrigine | Lamotrigine | 151 | 18 |
| Celecoxib | Celecoxib | 146 | 20 |
| Movantik | Naloxegol Oxalate | 146 | 14 |
| Trintellix | Vortioxetine Hydrobromide | 143 | suppressed |
| Meloxicam | Meloxicam | 139 | 26 |
| Paliperidone Er | Paliperidone | 135 | 14 |
| Budesonide | Budesonide | 134 | 43 |
| Bumetanide | Bumetanide | 134 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 129 | 32 |
| Nystatin | Nystatin | 128 | 74 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 124 | 38 |
| Invega Sustenna | Paliperidone Palmitate | 119 | 14 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 119 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 117 | 59 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 117 | 60 |
| Tizanidine Hcl | Tizanidine Hcl | 114 | 26 |
| Vascepa | Icosapent Ethyl | 114 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 112 | 40 |
| Levofloxacin | Levofloxacin | 111 | 68 |
| Atenolol | Atenolol | 110 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 109 | 19 |
| Entresto | Sacubitril/Valsartan | 104 | 15 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 104 | 29 |
| Ipratropium Bromide | Ipratropium Bromide | 103 | 31 |
| Oxybutynin Chloride | Oxybutynin Chloride | 103 | 21 |
| Propranolol Hcl | Propranolol Hcl | 103 | 19 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 101 | 21 |
| Pregabalin | Pregabalin | 100 | 21 |
| Rexulti | Brexpiprazole | 100 | 13 |
| Cefdinir | Cefdinir | 99 | 66 |
| Clonidine Hcl | Clonidine Hcl | 96 | 24 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 96 | 16 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 95 | 31 |
| Glipizide | Glipizide | 95 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 94 | 20 |
| Carbamazepine | Carbamazepine | 93 | suppressed |
| Ezetimibe | Ezetimibe | 93 | 14 |
| Farxiga | Dapagliflozin Propanediol | 93 | suppressed |
| Ingrezza | Valbenazine Tosylate | 93 | 11 |
| Latanoprost | Latanoprost | 93 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 93 | 49 |
| Bupropion Hcl Sr | Bupropion Hcl | 92 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 91 | 33 |
| Albuterol Sulfate | Albuterol Sulfate | 89 | 38 |
| Bupropion Xl | Bupropion Hcl | 89 | 17 |
| Gemtesa | Vibegron | 89 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 89 | 22 |
| Fenofibrate | Fenofibrate | 88 | 15 |
| Insulin Aspart Flexpen | Insulin Aspart | 85 | 29 |
| Lovastatin | Lovastatin | 80 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 80 | 13 |
| Cephalexin | Cephalexin | 79 | 41 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 79 | 46 |
| Doxepin Hcl | Doxepin Hcl | 78 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 78 | 16 |
| Invokana | Canagliflozin | 77 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 77 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 76 | 16 |
| Diltiazem Hcl | Diltiazem Hcl | 75 | suppressed |
| Nitroglycerin | Nitroglycerin | 72 | 54 |
| Linzess | Linaclotide | 70 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 68 | 15 |
| Glimepiride | Glimepiride | 67 | 14 |
| Metformin Hcl Er | Metformin Hcl | 67 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 66 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 66 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 66 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 63 | 25 |
| Morphine Sulfate | Morphine Sulfate | 63 | 23 |
| Chlorthalidone | Chlorthalidone | 62 | suppressed |
| Mirabegron Er | Mirabegron | 62 | 35 |
| Haloperidol | Haloperidol | 61 | 15 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 60 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 59 | 16 |
| Nifedipine Er | Nifedipine | 59 | suppressed |
| Roflumilast | Roflumilast | 59 | suppressed |
| Methotrexate | Methotrexate Sodium | 58 | suppressed |
| Nystop | Nystatin | 58 | 35 |
| Icosapent Ethyl | Icosapent Ethyl | 56 | suppressed |
| Methylprednisolone | Methylprednisolone | 56 | 48 |
| Premarin | Estrogens, Conjugated | 56 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 55 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 55 | suppressed |
| Fluconazole | Fluconazole | 55 | 43 |
| Lacosamide | Lacosamide | 55 | suppressed |
| Torsemide | Torsemide | 55 | suppressed |
| Brilinta | Ticagrelor | 53 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 53 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 53 | suppressed |
| Calcitriol | Calcitriol | 52 | suppressed |
| Levemir Flexpen | Insulin Detemir | 50 | 16 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 50 | 13 |
| Methenamine Hippurate | Methenamine Hippurate | 49 | suppressed |
| Methimazole | Methimazole | 49 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 49 | suppressed |
| Glipizide Er | Glipizide | 48 | suppressed |
| Insulin Aspart | Insulin Aspart | 47 | 14 |
| Lithium Carbonate | Lithium Carbonate | 47 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 47 | suppressed |
| Novolog Flexpen | Insulin Aspart | 46 | 19 |
| Ozempic | Semaglutide | 46 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 46 | suppressed |
| Lactulose | Lactulose | 45 | 18 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 45 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 44 | 20 |
| Erythromycin | Erythromycin Base | 43 | 25 |
| Nortriptyline Hcl | Nortriptyline Hcl | 43 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 43 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 43 | suppressed |
| Azithromycin | Azithromycin | 42 | 30 |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | 12 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 42 | 18 |
| Rivastigmine | Rivastigmine Tartrate | 42 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 41 | 15 |
| Metolazone | Metolazone | 41 | 11 |
| Phenobarbital | Phenobarbital | 41 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 41 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 40 | suppressed |
| Clonidine | Clonidine | 40 | suppressed |
| Glyburide | Glyburide | 40 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 40 | 18 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 39 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 39 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 39 | 11 |
| Acyclovir | Acyclovir | 38 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 38 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 38 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 37 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | 12 |
| Enulose | Lactulose | 37 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 37 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 36 | 35 |
| Spiriva Respimat | Tiotropium Bromide | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 22 |
| Amantadine | Amantadine Hcl | 35 | suppressed |
| Valsartan | Valsartan | 35 | suppressed |
| Ibuprofen | Ibuprofen | 34 | suppressed |
| Metronidazole | Metronidazole | 34 | 21 |
| Pilocarpine Hcl | Pilocarpine Hcl | 34 | suppressed |
| Timolol Maleate | Timolol Maleate | 34 | suppressed |
| Digoxin | Digoxin | 33 | suppressed |
| Methocarbamol | Methocarbamol | 33 | 13 |
| Sevelamer Carbonate | Sevelamer Carbonate | 33 | suppressed |
| Belbuca | Buprenorphine Hcl | 32 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 32 | suppressed |
| Humalog | Insulin Lispro | 32 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 32 | 12 |
| Estradiol | Estradiol | 31 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 31 | 20 |
| Mometasone Furoate | Mometasone Furoate | 31 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | 12 |
| Diazepam | Diazepam | 30 | suppressed |
| Ketoconazole | Ketoconazole | 30 | 14 |
| Santyl | Collagenase Clostridium Hist. | 30 | 19 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 30 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 29 | 25 |
| Diltiazem 24hr Er | Diltiazem Hcl | 29 | suppressed |
| Insulin Lispro | Insulin Lispro | 29 | suppressed |
| Loperamide | Loperamide Hcl | 29 | 17 |
| Anastrozole | Anastrozole | 28 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 28 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 28 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 28 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 28 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 27 | 14 |
| Flecainide Acetate | Flecainide Acetate | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 27 | suppressed |
| Sotalol | Sotalol Hcl | 27 | suppressed |
| Verapamil Sr | Verapamil Hcl | 27 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 26 | 26 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 26 | suppressed |
| Gemfibrozil | Gemfibrozil | 26 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 26 | suppressed |
| Naproxen | Naproxen | 26 | suppressed |
| Pentoxifylline | Pentoxifylline | 26 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | 14 |
| Glucagon Emergency Kit | Glucagon | 23 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 23 | 16 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Mupirocin | Mupirocin | 22 | 12 |
| Rivastigmine | Rivastigmine | 22 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 21 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 21 | suppressed |
| Olanzapine Odt | Olanzapine | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 21 | suppressed |
| Ursodiol | Ursodiol | 21 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 20 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 20 | 14 |
| Cyclosporine | Cyclosporine | 20 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 20 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 20 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 20 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 20 | suppressed |
| Modafinil | Modafinil | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Scopolamine | Scopolamine | 20 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 20 | suppressed |
| Azathioprine | Azathioprine | 19 | suppressed |
| Carbamazepine Er | Carbamazepine | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Rytary | Carbidopa/Levodopa | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 18 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 18 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | suppressed |
| Fluorometholone | Fluorometholone | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 18 | 18 |
| Restasis | Cyclosporine | 18 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 17 | suppressed |
| Humulin R | Insulin Regular, Human | 17 | suppressed |
| Linezolid | Linezolid | 17 | 14 |
| Naloxone Hcl | Naloxone Hcl | 17 | 14 |
| Niacin Er | Niacin | 17 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 13 |
| Atrovent Hfa | Ipratropium Bromide | 15 | suppressed |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 14 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | 12 |
| Proair Respiclick | Albuterol Sulfate | 14 | suppressed |
| Tacrolimus | Tacrolimus | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Fiasp Penfill | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Glatiramer Acetate | Glatiramer Acetate | 13 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Risperidone Odt | Risperidone | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 13 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
| Trulance | Plecanatide | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $921.90 · 39 records | Otsuka America Pharmaceutical, Inc. | AREXVY, AUSTEDO XR, Auvelity, BEXSERO, CAPLYTA, Cologuard Collection Kit, Dexcom G6 Transmitter, INGREZZA, MONOFERRIC, NURTEC ODT, Ozempic, QULIPTA, Qelbree, REPATHA, REXULTI, Rybelsus, SHINGRIX, The Cologuard Plus Collection Kit, Tymlos, UBRELVY, VRAYLAR, Wegovy, YUPELRI, ZAVZPRET, ZURZUVAE | 10 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Arexvy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error